Amdocs (Germany) Performance
| AOS Stock | EUR 83.02 0.00 0.00% |
Amdocs has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Amdocs are expected to decrease at a much lower rate. During the bear market, Amdocs is likely to outperform the market. Amdocs Limited right now shows a risk of 1.8%. Please confirm Amdocs Limited jensen alpha, maximum drawdown, and the relationship between the variance and sortino ratio , to decide if Amdocs Limited will be following its price patterns.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Amdocs Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Amdocs may actually be approaching a critical reversion point that can send shares even higher in January 2025. ...more
| Begin Period Cash Flow | 709.1 M | |
| Total Cashflows From Investing Activities | -262.5 M |
Amdocs |
Amdocs Relative Risk vs. Return Landscape
If you would invest 7,668 in Amdocs Limited on September 28, 2024 and sell it today you would earn a total of 634.00 from holding Amdocs Limited or generate 8.27% return on investment over 90 days. Amdocs Limited is currently producing 0.144% returns and takes up 1.7985% volatility of returns over 90 trading days. Put another way, 16% of traded stocks are less volatile than Amdocs, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Amdocs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amdocs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amdocs Limited, and traders can use it to determine the average amount a Amdocs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0801
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | AOS | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.8 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Amdocs is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amdocs by adding it to a well-diversified portfolio.
Amdocs Fundamentals Growth
Amdocs Stock prices reflect investors' perceptions of the future prospects and financial health of Amdocs, and Amdocs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amdocs Stock performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0652 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 10.29 B | |||
| Shares Outstanding | 120.59 M | |||
| Price To Earning | 22.06 X | |||
| Price To Book | 2.98 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 4.58 B | |||
| EBITDA | 899.33 M | |||
| Cash And Equivalents | 449.7 M | |||
| Cash Per Share | 3.28 X | |||
| Total Debt | 645.12 M | |||
| Debt To Equity | 3.30 % | |||
| Book Value Per Share | 29.42 X | |||
| Cash Flow From Operations | 756.72 M | |||
| Earnings Per Share | 4.18 X | |||
| Total Asset | 6.39 B | |||
About Amdocs Performance
By analyzing Amdocs' fundamental ratios, stakeholders can gain valuable insights into Amdocs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Amdocs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amdocs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company was founded in 1988 and is headquartered in Chesterfield, Missouri. AMDOCS LTD operates under Software - Infrastructure classification in Germany and is traded on Frankfurt Stock Exchange. It employs 25000 people.Things to note about Amdocs Limited performance evaluation
Checking the ongoing alerts about Amdocs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amdocs Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 99.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Amdocs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amdocs' stock is overvalued or undervalued compared to its peers.
- Examining Amdocs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amdocs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amdocs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amdocs' stock. These opinions can provide insight into Amdocs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Amdocs Stock analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |